CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 123 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q3 2023. The put-call ratio across all filers is 1.64 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,548,773 | +4.2% | 70,947 | +16.4% | 0.00% | 0.0% |
| Q2 2023 | $1,486,937 | 0.0% | 60,965 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $1,486,937 | -8.1% | 60,965 | +18.8% | 0.00% | 0.0% |
| Q4 2022 | $1,618,507 | -99.9% | 51,316 | +2.7% | 0.00% | 0.0% |
| Q3 2022 | $1,412,096,000 | -14.1% | 49,968 | -19.7% | 0.00% | 0.0% |
| Q2 2022 | $1,644,436,000 | +38.9% | 62,195 | +83.9% | 0.00% | 0.0% |
| Q1 2022 | $1,184,109,000 | +8.0% | 33,822 | 0.0% | 0.00% | – |
| Q4 2021 | $1,096,509,000 | +11.7% | 33,822 | +1.7% | 0.00% | – |
| Q3 2021 | $981,525,000 | – | 33,272 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BAIN CAPITAL INVESTORS LLC | 60,632,356 | $1,713,470,000 | 41.39% |
| Perceptive Advisors | 6,511,727 | $184,021,000 | 5.34% |
| Finepoint Capital LP | 536,901 | $15,173,000 | 4.99% |
| Artal Group S.A. | 2,000,000 | $56,520,000 | 2.41% |
| Rock Springs Capital Management LP | 2,499,148 | $70,626,000 | 1.82% |
| Ikarian Capital, LLC | 178,100 | $5,033,000 | 1.00% |
| Hood River Capital Management LLC | 896,572 | $25,337,000 | 0.97% |
| Frazier Life Sciences Management, L.P. | 393,000 | $11,106,000 | 0.86% |
| HighVista Strategies LLC | 23,611 | $667,000 | 0.38% |
| FEDERATED HERMES, INC. | 3,313,333 | $93,635,000 | 0.27% |